Abiopharma

中國商業創新正在重塑全球零售格局

Disclosure of Interest/ Changes in Interest of Director/ Chief Executive Officer: Disclosure of interest / Changes in interest of Director - Soo Kee Wee

Net Asset Value(s)

Disclosure of Interest/ Changes in Interest of Substantial Shareholder(s)/ Unitholder(s): Disclosure of interest / Changes in interest of substantial shareholder - Kau Wee Lee

Omdia：智能手机需求疲软推动维修翻新手机市场显示面板出货量创历史新高

Patient loyalty depends on more than access

General Announcement: Pricing of Offering of S$200,000,000 2.60 per cent. Notes due 2033

General Announcement: Adjustment Notice

FORM 6-K -Second Quarter 2026 Financial Results

Treace Medical Concepts Reports Second Quarter 2026 Financial Results